RESUMEN
BACKGROUND: 3-year subcutaneous specific immunotherapy (SIT) in children with seasonal allergic rhinoconjunctivitis reduced the risk of developing asthma during treatment and 2 years after discontinuation of SIT (5-year follow-up) indicating long-term preventive effect of SIT. OBJECTIVE: We evaluated the long-term clinical effect and the preventive effect of developing asthma 7-years after termination of SIT. METHODS: One hundred and forty-seven subjects, aged 16-25 years with grass and/or birch pollen allergy was investigated 10 years after initiation of a 3-year course of SIT with standardized allergen extracts of grass and/or birch or no SIT respectively. Conjunctival provocations were performed outside the season and methacholine bronchial provocations were performed during the season and winter. Asthma was assessed by clinical evaluation. RESULTS: The significant improvements in rhinoconjunctivitis and conjunctival sensitivity persisted at the 10-year follow-up. Significantly less actively treated subjects had developed asthma at 10-year follow-up as evaluated by clinical symptoms [odds ratio 2.5 (1.1-5.9)]. Patients who developed asthma among controls were 24/53 and in the SIT group 16/64. The longitudinal treatment effect when adjusted for bronchial hyper-responsiveness and asthma status at baseline including all observations at 3, 5 and 10 years follow-up (children with or without asthma at baseline, n = 189; 511 observations) was statistically significant (P = 0.0075). The odds ratio for no-asthma was 4.6 95% CI (1.5-13.7) in favor of SIT. CONCLUSION: A 3-year course of SIT with standardized allergen extracts has shown long-term clinical effects and the potential of preventing development of asthma in children with allergic rhinoconjunctivitis up to 7 years after treatment. CLINICAL IMPLICATION: Specific immunotherapy has long-term clinical effects and the potential of preventing development of asthma in children with allergic rhino conjunctivitis up to 7 years after treatment termination.
Asunto(s)
Alérgenos/uso terapéutico , Asma/prevención & control , Desensibilización Inmunológica/métodos , Rinitis Alérgica Estacional/prevención & control , Adolescente , Adulto , Alérgenos/inmunología , Antígenos de Plantas , Asma/complicaciones , Asma/inmunología , Betula/inmunología , Pruebas de Provocación Bronquial/métodos , Femenino , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Masculino , Oportunidad Relativa , Dimensión del Dolor/métodos , Proteínas de Plantas/inmunología , Proteínas de Plantas/uso terapéutico , Poaceae/inmunología , Polen , Rinitis Alérgica Estacional/complicaciones , Rinitis Alérgica Estacional/inmunología , Factores de Riesgo , Pruebas Cutáneas/métodos , TiempoRESUMEN
BACKGROUND: Subcutaneous immunotherapy has been the principal approach of immunotherapy in the treatment of allergic diseases. Several clinical studies with birch, alder or hazel pollen extract conducted as subcutaneous immunotherapy have been published suggesting a well-tolerated and clinically effective treatment. Only a few clinical studies of sublingual immunotherapy (SLIT) with these allergens have been published. This study investigated the clinical efficacy, safety and dose-response relationship of SLIT in children suffering from rhinoconjunctivitis with/without asthma. METHODS: Eighty-eight children (5-15 years) with a history of tree pollen-induced allergic rhinoconjunctivitis with/without seasonal asthma for >or=2 years were included. Allergy to tree pollen was confirmed by positive skin-prick test, positive specific IgE and positive conjunctival provocation test. The extract used was a glycerinated mixture of Betula verrucosa, Corylus avellana and Alnus glutinosa 100,000 SQ-U/ml. Children were randomized into three groups receiving SLIT 5 days a week for up to 18 months; dose group 1: accumulated weekly dose of 24,000 SQ-U; dose group 2: accumulated weekly dose of 200,000 SQ-U; and placebo. RESULTS: In the birch pollen season, dose group 2 showed a significant reduction of symptom (P = 0.01) and medication scores (P = 0.04) compared with placebo. Dose group 1 showed a significant reduction of symptom scores (P = 0.03). There were no statistical differences between dose groups 1 and 2. All children tolerated the treatment well. CONCLUSION: SLIT with tree pollen extract provided dose-dependent benefits in tree pollen-allergic children in terms of significantly reduced symptoms and medication use. The treatment was well tolerated.
Asunto(s)
Alérgenos/administración & dosificación , Conjuntivitis Alérgica/terapia , Inmunoterapia , Polen/inmunología , Rinitis Alérgica Estacional/complicaciones , Árboles/inmunología , Administración Sublingual , Adolescente , Alérgenos/efectos adversos , Alnus/efectos adversos , Alnus/inmunología , Betula/efectos adversos , Betula/inmunología , Estudios de Casos y Controles , Niño , Preescolar , Conjuntivitis Alérgica/inmunología , Corylus/efectos adversos , Corylus/inmunología , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Masculino , Extractos Vegetales/efectos adversos , Extractos Vegetales/inmunología , Polen/efectos adversos , Rinitis Alérgica Estacional/terapia , Pruebas Cutáneas , Factores de Tiempo , Resultado del Tratamiento , Árboles/efectos adversos , Árboles/clasificaciónRESUMEN
BACKGROUND: A 3-year course of specific immunotherapy (SIT) in children with hay fever to grass and/or birch pollen significantly reduced the risk of developing asthma. To investigate the long-term preventive effect, we performed a follow up--2 years after termination of immunotherapy. METHODS: A total of 183 children, aged 6-14 years with grass and/or birch pollen allergy could be investigated 2 years after discontinuation of SIT or no treatment. Conjunctival provocation tests (CPTs) and methacholine bronchial provocation tests were carried out during the season and winter after 5 years. The development of asthma was assessed by clinical evaluation. RESULTS: The significant improvement in hay fever and CPT results observed after 3 years of SIT persisted at the 5-year follow-up. No difference in bronchial responsiveness to methacholine was found after 5 years because of spontaneous improvement during the follow-up period in the control patients. The immunotherapy-treated children had significantly less asthma after 5 years as evaluated by clinical symptoms [odds ratio 2.68 (1.3-5.7)] in favor of SIT for prevention of development of asthma and significantly less patients reported an increase in asthma scores (P < 0.01). CONCLUSION: Immunotherapy for 3 years with standardized allergen extracts of grass and/or birch shows long-term clinical effect and preventive effect on development of asthma in children with seasonal rhinoconjunctivitis.
Asunto(s)
Alérgenos/uso terapéutico , Asma/prevención & control , Desensibilización Inmunológica , Proteínas de Plantas/uso terapéutico , Rinitis Alérgica Estacional/terapia , Adolescente , Antígenos de Plantas , Asma/epidemiología , Asma/inmunología , Betula/inmunología , Niño , Femenino , Estudios de Seguimiento , Humanos , Masculino , Oportunidad Relativa , Poaceae/inmunología , Polen/inmunología , Rinitis Alérgica Estacional/inmunologíaRESUMEN
The aim of this study was to determine whether there are regional differences in the prevalence of childhood asthma in Finland. A secondary objective was to assess the concordance between a written and a video questionnaire on asthma symptoms. In 1994-1995, the self-reported prevalence of asthma symptoms in four regions of Finland was studied among 11,607 schoolchildren aged 13-14 yrs, as part of the International Study of Asthma and Allergies in Childhood (ISAAC). The ISAAC written and video (AVQ 3,0) questionnaires were administered in the school setting. The prevalences of any wheezing during the previous 12 months in the ISAAC video questionnaire were 10% in East Finland (Kuopio County, n=2,821), 12% in South Finland (Helsinki area, n=2,771), 12% in Southwest Finland (Turku and Pori County, n=2,983), and 11% in North Finland (Lapland, n=3,032). The prevalences in the ISAAC written questionnaire were 13, 20, 15, and 16%, respectively. The surveys were performed during winter, except in Helsinki where the survey was carried out mainly during the spring pollen season. During autumn, the prevalence in the written questionnaire in Helsinki was 16%. In multivariate analysis, boys had a lower prevalence than girls, and smokers a threefold higher prevalence than nonsmokers. In conclusion, the prevalence of childhood asthma is lower in Finland than in other European countries, and may be even lower in the eastern part of the country. In contrast to the results from some other European countries, prevalences were lower in the video than in the written questionnaire, which suggests that translating the word "wheezing" into other languages, including Finnish, may produce results that cannot be compared. The strong association of smoking with wheeze both in the video and written questionnaires should be considered in further analysis of the ISAAC study.
Asunto(s)
Asma/epidemiología , Adolescente , Asma/fisiopatología , Demografía , Femenino , Finlandia , Encuestas Epidemiológicas , Humanos , Hipersensibilidad/epidemiología , Masculino , Análisis Multivariante , Polen , Prevalencia , Ruidos Respiratorios , Estaciones del Año , Distribución por Sexo , Fumar , Encuestas y Cuestionarios , TelevisiónRESUMEN
Two particle samplers for ambient air, situated together: a static size-selective bio-aerosol sampler (SSBAS) and a Burkard pollen and spore trap were compared in sampling intact birch pollen grains through one flowering period of Betula (a total of 44 days). The SSBAS trapped pollen grains three times more efficiently than the Burkard trap, but the variations in pollen counts were significantly correlated. In contrast, birch pollen antigenic activity and the pollen count in the Burkard samples were not closely correlated. The antigenic concentration was occasionally high both before and after the pollination period. There was a high birch pollen antigenic activity in particle size classes where intact pollen grains were absent, even on days when the pollen count was very low. Correspondingly, on days with high birch pollen counts in the air, pollen antigenic activity was on several occasions low, indicating that pollen grains were empty of antigenic material. The small particle size classes are especially important to allergic patients because they are able to penetrate immediately into the alveoli and provoke asthmatic reactions. Therefore, aerobiological information systems based on pollen and spore counts should be supplemented with information concerning antigenic activities in the air.
Asunto(s)
Contaminantes Atmosféricos/análisis , Antígenos/análisis , Monitoreo del Ambiente/métodos , Polen , Animales , Ensayo de Inmunoadsorción Enzimática , Técnicas para Inmunoenzimas , Conejos , Estaciones del AñoRESUMEN
Stability of Candida albicans allergens was studied under various storage conditions. Lyophilized extract was reconstituted with human serum albumin (NSA) diluent, glycerol-free and in the presence of 10% or 50% glycerol and stored at various temperatures for different time periods. All extracts were tested at the same time with immunoblotting using C. albicans allergic patient sera and galactosidase-labelled anti-IgE. The highest number of detected allergens in the immunoblotting pattern was found in the presence of 50% glycerol at +6 degrees C. The most important allergen of C. albicans, the 46 kD protein allergen was stable up to 10 weeks at +6 degrees C in the presence of 50% glycerol but thereafter began to lose its IgE-binding capacity. After 30 weeks more than 50% of the IgE binding had disappeared. The 27 kD protein, another important allergen, was also labile but retained the allergenicity better than the 46 kD one. The 29 kD protein allergen was stable at all storage conditions, except +37 degrees C tested even after one year. More than 6 months storage at +6 degrees C or higher temperature is, however, unacceptable even in the presence of the 50% glycerol. These findings have particular importance in the diagnosis and treatment of allergic diseases.
Asunto(s)
Alérgenos/inmunología , Candida albicans/inmunología , Preservación Biológica , Alérgenos/química , Densitometría , Estabilidad de Medicamentos , Humanos , Immunoblotting , Inmunoglobulina E/inmunología , Extractos Vegetales/análisis , Coloración y EtiquetadoRESUMEN
Pollen and spore counts from Burkard traps for routine pollen and spore sampling placed at 15 m above ground and at ground level were compared. Daily counts of most pollen types were higher on the ground than at roof level, but the counts were significantly correlated. The ratios of pollen frequencies at high and low levels varied between 1.0 and 11.5. The most prominent differences were recorded for herbaceous pollen (e.g. Artemisia counts 11.5 and Poaccae counts 4.4 times higher at ground level) and in Botrytis and Ustilaginales spores. Tree pollen grains and basidiomycetous spores were more equally distributed. Wind speed did not affect the variation of pollen frequencies at either height. Large spores are not so unevenly distributed as previously supposed. Artemisia and grass pollen was detected 1 to 2 weeks earlier at ground level than on the roof. It is therefore concluded that especially the beginning of flowering should be monitored at a low level.
Asunto(s)
Contaminantes Atmosféricos/análisis , Monitoreo del Ambiente , Monitoreo del Ambiente/métodos , Humanos , Polen , Esporas/análisisRESUMEN
A new bioaerosol sampler consisting of Liu-type atmospheric aerosol sampling inlet, coarse particle inertial impactor, two-stage high-efficiency virtual impactor (aerodynamic particle sizes respectively in diameter: greater than or equal to 8 microns, 8-2.5 microns, and 2.5 microns; sampling on filters) and a liquid-cooled condenser was designed, fabricated and field-tested in sampling birch (Betula) pollen grains and smaller particles containing Betula antigens. Both microscopical (pollen counts) and immunochemical (enzyme-linked immunosorbent assay) analyses of each stage were carried out. The new sampler was significantly more efficient than Burkard trap e.g. in sampling particles of Betula pollen size (ca. 25 microns in diameter). This was prominent during pollen peak periods (e.g. May 19th, 1985, in the virtual impactor 9482 and in the Burkard trap 2540 Betula p.g. X m-3 of air). Betula antigens were detected also in filter stages where no intact pollen grains were found; in the condenser unit the antigen concentrations instead were very low.
Asunto(s)
Antígenos/análisis , Polen/inmunología , Aerosoles , MétodosRESUMEN
Occurrence of airborne pollen in Finland has been studied for 10 years in Turku (southern Finland), 8 years in Oulu, 4 years in Kuopio (central Finland) and 7 years at Kevo (northern Lapland). Observations on the pollen seasons of alder, birch, grasses and mugwort are presented. All these pollens occur in south and mid- Finland in quantities capable of causing allergy symptoms. Except for birch pollen, allergenic pollens occur in far lower concentrations than in central Europe. In northern Lapland only birch and pine pollen concentrations are high. Pollens may occur without signs of local flowering when there are southerly winds. This finding suggests that long-distance transport is an essential contributing factor to the occurrence of pollens. There are wide year-to-year variations in the start of pollen seasons and the quantities of pollens. The variations in the start of birch and grass pollen seasons could very much depend on the mean temperature in April. However, a forecasting model based on this and other spring-time temperature parameters often fails to give sufficiently accurate forecasts.
Asunto(s)
Polen , Estaciones del Año , Finlandia , Predicción , Humanos , Conceptos Meteorológicos , Poaceae , Rinitis Alérgica Estacional/etiología , ÁrbolesRESUMEN
A 2 year prospective study of thirty-eight birch pollen-sensitive hay fever patients under specific immunotherapy and of nineteen untreated control patients showed a significant correlation between the total seasonal symptom scores of the patients and their clinical sensitivities assessed by the RAST and a graded nasal test. The agreement between a positive nasal test and a positive RAST was 74%. In the early season with low pollen counts the onset of symptoms was significantly associated with high sensitivity of the patients, while many patients showed symptoms in the late season irrespective of their nasal and RAST sensitivity. About 90% of both the treated and the untreated patients reported mild symptoms when the pollen count exceeded 80/m(3) in the early season. 80% of them still had symptoms when the count was below 30/m(3) in the late pollen season. Although hyposensitization therapy had no effect on the occurrence of the mild symptoms, the treated patinets had severe symptoms significantly less often than the untreated ones on days with high pollen counts.